Search results
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Investor's Business Daily· 4 hours agoMeanwhile, Lilly locked up its acquisition of Point Biopharma, an expert in radioligand treatments...
Here’s why a Florida company recalled its male sexual enhancement drugs sold on Amazon
Miami Herald via Yahoo News· 8 hours ago“People with diabetes, high blood pressure, high cholesterol, or heart disease often...
Analyst Report: Bristol-Myers Squibb Company
Morningstar Research via Yahoo Finance· 3 hours agoBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where ...
US FDA sends warning to Cardinal Health for marketing unapproved devices
WHTC 1450 Holland· 2 hours ago(Reuters) - The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal...
Justice Department is investigating McKinsey consulting firm’s role in opioid epidemic
KEYT 3 Santa Barbara· 1 hour agoProsecutors from Virginia and Massachusetts are leading the criminal investigation, the sources...
American Business Awards: Dr. Siva Mohan, CMO of RazorMetrics
Morningstar· 28 minutes agoCo-founder of RazorMetrics is Silver Stevie Winner for Best Entrepreneur - Health Products & Services AUSTIN, Texas, April 25, 2024 /PRNewswire/ -- Dr. Siva Mohan, Co-Founder and Chief Medical ...
Senate committee opens investigation into Ozempic, Wegovy prices
Scripps News via AOL· 4 hours agoThe demand in the U.S. caused a shortage. In an announcement Thursday, the Senate committee said the...
Diabetes Devices Giant Crumbles Despite Beat-And-Raise
Investor's Business Daily· 44 minutes agoThe company raised the lower bound of its sales guidance for the year.
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via Yahoo Finance· 10 hours ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of...
Xaira Therapeutics $1 billion funding round shows the excitement about AI drug discovery
Fortune· 6 hours agoThe pursuit to use AI to discover new life-saving drugs got a big boost this week when a new company, Xaira Therapeutics, emerged from stealth with $1 billion in funding.